Cargando…

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF. The aim of the study was to investigate whether serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berezin, Alexander A., Lichtenauer, Michael, Boxhammer, Elke, Stöhr, Eric, Berezin, Alexander E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496790/ https://www.ncbi.nlm.nih.gov/pubmed/36139374 http://dx.doi.org/10.3390/cells11182794

Ejemplares similares

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
por: Berezin, Alexander A., et al.
Publicado: (2023)

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2021)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Epigenetics in heart failure phenotypes()
por: Berezin, Alexander
Publicado: (2016)

Editorial: Acute heart failure: From bench to bedside
por: Berezin, Alexander E., et al.
Publicado: (2023)

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
por: Berezin, Alexander E.
Publicado: (2016)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
por: Berezin, Alexander E., et al.
Publicado: (2021)

Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023)

The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation
por: Berezin, Alexander A., et al.
Publicado: (2022)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2015)

Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Boxhammer, Elke, et al.
Publicado: (2022)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review
por: Berezin, Alexander E., et al.
Publicado: (2020)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities
por: Berezin, Alexander E., et al.
Publicado: (2022)

The signature of circulating microparticles in heart failure patients with metabolic syndrome
por: Berezin, Alexander E, et al.
Publicado: (2016)

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2014)

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease
por: Berezin, Alexander E., et al.
Publicado: (2016)

The predictive role of circulating microparticles in patients with chronic heart failure()
por: Berezin, Alexander E., et al.
Publicado: (2014)

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
por: Berezin, Alexander E., et al.
Publicado: (2015)

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
por: Berezin, Alexander E., et al.
Publicado: (2020)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

The utility of biomarker risk prediction score in patients with chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2016)

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2014)

Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus
por: AL-Ghazali, Majid Jawad, et al.
Publicado: (2020)

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2015)

Serum Irisin Levels and Clinical Implication in Elderly Patients With Type 2 Diabetes Mellitus
por: Xuan, Xianfa, et al.
Publicado: (2020)

Abstract 35: A study on serum irisin levels in type 2 diabetes mellitus
por: Gumpina, Srinivas Susheel
Publicado: (2022)

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
por: Berezin, Alexander E., et al.
Publicado: (2016)

Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations
por: Berezin, Alexander E.
Publicado: (2015)

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wang, Qiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kfh17842vmi73anma50hccc2b